<DOC>
	<DOCNO>NCT00239616</DOCNO>
	<brief_summary>This open-label , multicenter pharmacokinetic study HD od PD patient receive erythropoietin . Patients administer 100mg iron sucrose undiluted slow IV push 5 minute . Patients underwent serial blood draw subsequently follow 7 day safety endpoint .</brief_summary>
	<brief_title>Pharmacokinetic Study Intravenous Iron Sucrose Adolescents Hemodialysis Peritoneal Dialysis Receiving Epoetin</brief_title>
	<detailed_description>This open-label , multicenter pharmacokinetic study HD adolescent PD patient receive erythropoietin . Patients age 12 18 administer 100mg iron sucrose , undiluted slow IV push 5 minute , underwent serial blood draw . The patient subsequently follow 7 day safety endpoint .</detailed_description>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Age 12 18 History Chronic Renal Failure require HD PD Hgb &lt; /= 13 g/dL Ferritin &lt; 800 ng/ml TSAT &lt; 50 % Receiving EPO Known Sensitivity Iron Sucrose Severe Concomitant disease liver cardiovascular system Serious bacterial Infection Pregnancy / Lactation Active Hepatitis Patients Causes iron deficiency Chronic Renal Failure Blood Transfusion Body Weight &lt; 25 KG Currently treat Asthma Received investigational drug within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>